Angiotensin Converting Enzyme Inhibitor class drugs

10 results
  • benazepril hydrochloride and hydrochlorothiazide

    (Benazepril Hydrochloride and Hydrochlorothiazide)
    ANI Pharmaceuticals, Inc.
    Benazepril hydrochloride and hydrochlorothiazide tablets are indicated for the treatment of hypertension. This combination medication is not intended for initial hypertension therapy.
  • captopril

    (Captopril)
    Ajanta Pharma USA Inc.
    Captopril is indicated for treating hypertension, heart failure, left ventricular dysfunction post-myocardial infarction, and diabetic nephropathy in type I diabetes patients. It is effective alone or with other antihypertensives and can improve survival and reduce hospitalizations in specific heart failure patients. Caution is advised in certain populations.
  • captopril

    (captopril)
    Method Pharmaceuticals LLC
    Captopril is indicated for treating hypertension, congestive heart failure, improving survival in post-myocardial infarction patients with left ventricular dysfunction, and diabetic nephropathy in type 1 diabetes. It is effective alone or with diuretics and required careful consideration of risks in patients with renal impairment or specific demographics.
  • enalapril maleate

    (Enalapril maleate)
    Wilshire Pharmaceuticals, Inc.
    Enalapril maleate is indicated for treating hypertension in adults and children over one month, reducing cardiovascular risks. It also treats symptomatic heart failure, enhancing survival and reducing hospitalizations. Additionally, it benefits asymptomatic patients with left ventricular dysfunction by decreasing heart failure development and related hospitalizations.
  • enalapril maleate

    (Enalapril maleate)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Enalapril maleate tablets are indicated for treating hypertension, symptomatic congestive heart failure, and asymptomatic left ventricular dysfunction. They can be used alone or with other antihypertensives, improving symptoms and reducing hospitalization in heart failure patients. Caution is advised in patients with specific health conditions and demographics.
  • epaned

    (enalapril maleate)
    Azurity Pharmaceuticals, Inc.
    EPANED is indicated for treating hypertension in adults and children over one month, improving cardiovascular outcomes. It is also indicated for symptomatic heart failure, often with diuretics and digitalis, enhancing survival and reducing hospitalizations, and for asymptomatic left ventricular dysfunction, decreasing progression to overt heart failure.
  • ramipril

    (Ramipril)
    Rising Pharma Holdings, Inc.
    Ramipril capsules are indicated for treating hypertension, reducing cardiovascular event risks (myocardial infarction, stroke, death) in high-risk patients aged 55 or older, and managing heart failure following myocardial infarction. They may be used alone or in combination with other therapies to achieve desired outcomes.
  • ramipril

    (Ramipril)
    Chartwell RX, LLC.
    Ramipril capsules are indicated for treating hypertension to lower blood pressure, reducing cardiovascular event risks. They are also used in stable patients with heart failure post-myocardial infarction to decrease death risk and hospitalizations. This medication can be used alone or with thiazide diuretics.
  • trandolapril and verapamil hydrochloride

    (Trandolapril and Verapamil Hydrochloride)
    Glenmark Pharmaceuticals Inc., USA
    Trandolapril and verapamil hydrochloride extended-release tablets are indicated for treating hypertension. This fixed combination drug is not recommended for initial hypertension therapy. Caution is advised due to potential risks, such as agranulocytosis, especially in patients with renal impairment or collagen vascular disease.
  • vasotec

    (Enalapril Maleate)
    Bausch Health US LLC
    VASOTEC is indicated for treating hypertension, symptomatic congestive heart failure, and asymptomatic left ventricular dysfunction. It can be used alone or with other antihypertensives, improves heart failure symptoms and survival, and reduces hospitalization rates in patients with left ventricular dysfunction.